Masahito Nakano

26PUBLICATIONS
23CO-AUTHORS
Haematological tumoursFish pests and diseasesSocio-economic developmentCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Feb 24, 2026
Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report.

Etsuko Moriyama, Hironori Koga, Takashi Niizeki

|Nov 20, 2025
A case of hypovascular hepatic lesion with suspected clonorchiasis.

Masahito Nakano, Machiko Kawaguchi, Reiichiro Kondo

|Oct 30, 2025
Nationwide Trends in Liver Stiffness Measurement in Japan: A Real-World Evidence of NILDA Using the National Database of Health Insurance Claims.

Masahito Nakano, Machiko Kawaguchi, Kotaro Kuwaki

|May 31, 2025
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria.

Takashi Niizeki, Seiichi Mawatari, Michihiko Shibata

|May 12, 2025
Liver cirrhosis in metabolic dysfunction-associated steatohepatitis.

Donghyun Ko, Do Han Kim, Pojsakorn Danpanichkul

|May 03, 2025
Efficacy and safety of lenvatinib-transcatheter arterial chemoembolization sequential therapy for hepatocellular carcinoma within the up-to-seven criteria.

Shigeo Shimose, Takashi Niizeki, Hideki Iwamoto

Pageof 5

Frequent Collaborators

14 joint publications

Takumi Kawaguchi

13 joint publications

Shigeo Shimose

11 joint publications

Hironori Koga

9 joint publications

Tomotake Shirono